ArticleCancer immunology, immunotherapy : CII2022

Severe immune-related adverse events of immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials.

Jingjing Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.